Zobrazeno 31 - 40
of 227
pro vyhledávání: '"Shigeki Ohtake"'
Autor:
Yoshinori Tanaka, Naoyuki Uchida, Heiwa Kanamori, Noriko Doki, Shigeki Ohtake, Toru Sakura, Kazuhiro Ikegame, Shuichi Ota, Fumihiko Hayakawa, Yasushi Miyazaki, Shinichi Kako, Shingo Kurahashi, Shuichi Mizuta, Itaru Matsumura, Yoshiko Atsuta, Satoshi Nishiwaki, Tohru Murayama, Tatsuo Ichinohe, Noriko Usui, Takahiro Fukuda, Hitoshi Kiyoi, Kiyotoshi Imai, Junji Tanaka
Publikováno v:
Blood. 134:4589-4589
[Background] We previously demonstrated that allogeneic hematopoietic stem cell transplantation (HSCT) in the first complete remission (CR1) was recommended for adult patients wih Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (AL
Autor:
Yoshiko Atsuta, Satoshi Nishiwaki, Tomoko Hata, Yasushi Miyazaki, Youko Suehiro, Yukiyasu Ozawa, Noboru Asada, Hisayuki Yokoyama, Toshiro Ito, Yasuhiro Taniguchi, Koh Shiro, Shigeki Ohtake, Ryuko Cho, Noriko Doki, Yasushi Onishi, Shinichi Kako, Kazuteru Ohashi, Fumihiko Hayakawa, Isamu Sugiura, Mitsuhiro Matsuda, Shin Fujisawa, Heiwa Kanamori, Maki Hagihara, Yoshihiro Hatta, Nobuaki Dobashi
Publikováno v:
Blood. 134:743-743
Background: The Japan Adult Leukemia Study Group (JALSG) conducted the Ph+ALL202 and Ph+ALL208 studies for newly diagnosed (ND) Philadelphia-chromosome (Ph)-positive acute lymphoblastic leukemia (ALL), and successfully introduced imatinib into intens
Autor:
Naoko Hosono, Nobuhiro Hiramoto, Shuichi Miyawaki, Yoshinobu Kanda, Hiroyuki Fujita, Shigeki Ohtake, Hitoshi Kiyoi, Itaru Matsumura, Tomoki Naoe, Minoru Yoshida, Hiroshi Handa, Hitoshi Minamiguchi, Shun-ichi Kimura, Jun-ichi Miyatake, Tsutomu Takahashi, Yasushi Miyazaki, Hideaki Kato, Nobu Akiyama, Kazuyuki Shigeno
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(12)
The Japan Adult Leukemia Study Group (JALSG) AML201 protocols are regimens for remission induction and consolidation chemotherapy of acute myeloid leukemia (AML) and have been widely accepted in Japan since 2001. Management of infectious complication
Autor:
Yoshiharu Tokita, Hiromitsu Shinozaki, Takayuki Saitoh, Ayako Igarashi, Hiroki Matsui, Hideomi Watanabe, Shiomi Kanaizumi, Fusae Tozato, Noriko Tabuchi, Shigeki Ohtake, Yumiko Abe, Mika Sato, Akinori Kama, Michiko Inagaki, Bumsuk Lee, Takatoshi Makino
Publikováno v:
Journal of interprofessional care. 32(2)
There have been few studies comparing the attitudes towards healthcare teams between different universities. This study analysed the differences in attitudes towards healthcare teams between health science students at Gunma University, Japan, which i
Autor:
Hiroyuki Fujita, Shun-ichi Kimura, Nobuhiro Hiramoto, Shuichi Miyawaki, Yoshinobu Kanda, Itaru Matsumura, Jun-ichi Miyatake, Tsutomu Takahashi, Yasushi Miyazaki, Hideaki Kato, Minoru Yoshida, Nobu Akiyama, Naoko Hosono, Kazuyuki Shigeno, Tomoki Naoe, Shigeki Ohtake, Hiroshi Handa, Hitoshi Minamiguchi, Hitoshi Kiyoi
Publikováno v:
Open Forum Infectious Diseases
Background Remission induction (RI) chemotherapy for acute myeloid leukemia (AML) is one of the most intensive chemotherapy available. Antibiotic prophylaxis and prompt treatment for infectious complications during RI chemotherapy play a major role i
Autor:
Keitaro Matsuo, Eriko Morishita, Takehiko Mori, Akiyoshi Takami, J. Luis Espinoza, Koichi Kashiwase, Haruka Nomoto, Shinji Nakao, Makoto Onizuka, Shohei Mizuno, Takahiro Fukuda, Shigeki Ohtake, Koichi Miyamura, Yoshihisa Kodera, Noriko Doki, Yasuo Morishima
Publikováno v:
International Journal of Hematology. 102:460-470
Thrombomodulin, encoded by the THBD gene, is a critical regulator of coagulation and innate immunity. Its gene variant (rs3176123, 2729A>C) in the 3′ untranslated region has been reported to be associated with vasculopathies. The present study anal
Autor:
Kazunori Ohnishi, Yukio Kobayashi, Nobuhiko Emi, Nobuaki Dobashi, Toru Sakura, Hiroshi Gomyo, Yasunori Ueda, Masashi Sawa, Etsuko Yamazaki, Norio Asou, Yoshihiro Hatta, Yasushi Miyazaki, Shigehisa Tamaki, Tomoki Naoe, Minoru Kojima, Katsumichi Fujimaki, Keitaro Matsuo, Masamitsu Yanada, Jun-ichi Miyatake, Shigeki Ohtake, Katsuji Shinagawa
Publikováno v:
Journal of Clinical Oncology. 32:3729-3735
Purpose The introduction of all-trans-retinoic acid (ATRA) has significantly improved outcomes for acute promyelocytic leukemia (APL), although a subset of patients still suffer relapse. The purpose of this study was to evaluate the role of maintenan
Autor:
Yoshiko Atsuta, Yasuhiko Miyata, Maho Ishikawa, Tetsuya Fukuda, Noriko Usui, Shinichi Kobayashi, Tetsuzo Tauchi, Hiroshi Gomyo, Kazunori Ohnishi, Yasushi Miyazaki, Kohshi Ohishi, Naoto Takahashi, Katsumichi Fujimaki, Hitoshi Suzushima, Kiyotoshi Imai, Koichi Miyamura, Takaaki Miyake, Yoshio Saburi, Tomoki Naoe, Kensuke Usuki, Satoru Takada, Itaru Matsumura, Yukio Kobayashi, Osamu Sasaki, Shigeki Ohtake, Hitoshi Kiyoi, Yoshihiro Hatta, Toru Kiguchi, Kunio Kitamura, Yosuke Minami, Kazuto Togitani, Hideki Mitsui
Publikováno v:
International journal of hematology. 107(2)
The objective of this prospective clinical trial (JALSG-STIM213, UMIN000011971) was to evaluate treatment-free remission (TFR) rates after discontinuation of imatinib in chronic myeloid leukemia (CML). CML patients who received imatinib treatment for
Autor:
Akio Tawa, Toru Sakura, Takashi Taga, Shuichi Miyawaki, Nobutaka Kiyokawa, Kunio Kitamura, Takao Deguchi, Hayato Miyachi, Yuka Iijima-Yamashita, Youko Suehiro, Yasunobu Nagata, Yasushi Miyazaki, Daisuke Tomizawa, Yachiyo Kuwatsuka, Heiwa Kanamori, Emiko Sakaida, Katsuyoshi Koh, Hiroaki Goto, Yukiyasu Ozawa, Norio Shiba, Yoshiyuki Kosaka, Kiyotoshi Imai, Noriko Usui, Shigeki Ohtake, Akira Shimada, Yoshikazu Ito, Akiko Saito, Yasuhide Hayashi, Tomoki Naoe, Shuki Mizutani, Atsushi Manabe, Souichi Adachi, Keizo Horibe, Hideki Nakayama, Rika Kihara, Akitoshi Kinoshita, Seishi Ogawa, Shinichi Kobayashi, Norio Asou, Hitoshi Kiyoi
Publikováno v:
International journal of hematology. 107(2)
Clinical outcomes and the genetic background of acute myeloid leukemia (AML) in adolescent and young adults (AYAs) are known to differ in younger children and older adults. To clarify the impact of genetic mutations on clinical outcomes of AYAs with
Autor:
Toru Kiguchi, Toru Sakura, Chiaki Nakaseko, Fangli Chen, Yasunobu Nagata, Kunio Kitamura, S Miyawaki, Satoru Miyano, Kenichi Chiba, Hirokazu Tanaka, E Yamamoto, K Imai, Naokuni Uike, Seishi Ogawa, Hitoshi Suzushima, Fumihiko Kimura, Yukiyasu Ozawa, Heiwa Kanamori, Rika Kihara, Yasuhiko Miyazaki, Yuichi Shiraishi, Kyogo Suzuki, Shigeki Ohtake, Akihiro Takeshita, Norio Asou, Y Kato, Hitoshi Kiyoi, M Onizuka, Hiroshi Miwa, Noriko Usui, Tomoki Naoe, Fumihiro Ishida, Tomonori Kato
Publikováno v:
Leukemia. 28:1586-1595
To clarify the cooperative roles of recurrently identified mutations and to establish a more precise risk classification system in acute myeloid leukemia (AML), we comprehensively analyzed mutations in 51 genes, as well as cytogenetics and 11 chimeri